bioMérieux S.A. (BMXXY)

Market Cap	12.15B -18.3%
Revenue (ttm)	4.78B +2.3%
Net Income	466.71M -8.0%
EPS	3.92 -8.2%
Shares Out	n/a
PE Ratio	26.03
Forward PE	18.76
Dividend	0.06 (0.47%)
Ex-Dividend Date	Jun 10, 2025

Volume	10,811
Average Volume	8,624
Open	10.80
Previous Close	n/a
Day's Range	10.80 - 12.11
52-Week Range	9.90 - 14.62
Beta	0.66
RSI	52.41
Earnings Date	Jul 28, 2026

About bioMérieux

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1963
• Employees: 14,894
• Stock Exchange: OTCMKTS
• Ticker Symbol: BMXXY

Financial Performance

In 2025, bioMérieux's revenue was 4.07 billion, an increase of 2.26% compared to the previous year's 3.98 billion. Earnings were 397.50 million, a decrease of -8.03%.

Financial numbers in EUR